The HSPA4L Knockout Jurkat Polyclonal Cells represent a CRISPR/Cas9-edited polyclonal knockout cell population featuring targeted disruption of the HSPA4L gene within the Jurkat human T lymphocyte line. This loss-of-function model is designed for advanced biomedical research into the molecular chaperone and nucleotide exchange factor HSPA4L, providing a versatile tool to dissect its contributions to protein homeostasis, stress signaling, and immune cell function under native regulatory contexts. The polyclonal nature of the knockout pool preserves heterogeneity while eliminating wild-type HSPA4L activity, allowing assessment of gene disruption effects across a diverse genetic background without single-cell cloning biases. As a catalogue product, these cells are validated for robust growth and maintained under standard culture conditions, serving as a ready-to-use resource for mechanistic studies and drug discovery pipelines.
Jurkat cells, the host line, are an immortalized human T lymphocyte line derived from an acute lymphoblastic leukemia patient. They are extensively employed as a model system for dissecting T cell receptor signaling, cytokine production, apoptosis, and general immune effector functions. Characterized by constitutive activation of key signaling cascades such as MAPK and NF-??B pathways, Jurkat cells offer a tractable platform for studying stress-induced adaptations, protein quality control mechanisms, and the molecular basis of T cell malignancies. Their uniform immortalized state ensures reproducible experimental outcomes, making them a standard choice for biochemical, pharmacological, and genetic manipulation studies in immunology and cancer biology.
HSPA4L encodes a member of the HSP110 family, functioning as a nucleotide exchange factor for Hsp70 to facilitate the cycling of ATP hydrolysis and promote efficient protein folding and refolding. Its activity is critically induced under stress conditions: heat shock, oxidative stress, and TNF-?? signaling drive transcriptional upregulation via HSF1, a master transcription factor of the heat shock response. HSPA4L interacts physically with HSPA1A (the major stress-inducible Hsp70), the co-chaperone DNAJB1, the ubiquitin ligase STUB1, and various BAG family proteins, forming dynamic complexes that either aid proper folding or target misfolded substrates for degradation. Downstream, HSPA4L acts on denatured proteins and protein aggregates to prevent toxic accumulation and maintain proteostasis. Positioned within the protein processing in the endoplasmic reticulum pathway, the heat shock response, MAPK signaling, and apoptosis networks, HSPA4L links extracellular stress stimuli to intracellular chaperone machinery, coordinating with HSP90AA1, HSPB1, and MAP kinases to modulate cell survival decisions.
The ablation of HSPA4L in Jurkat T lymphocytes provides a compelling model to examine how nucleotide exchange factor activity intersects with T cell stress biology. Given the role of chaperone networks in regulating apoptosis, loss of HSPA4L may sensitize these cells to heat shock, oxidative damage, or inflammatory cytokines, unveiling protective mechanisms that are often co-opted by cancers to evade cell death. The polyclonal knockout pool allows observation of population-level responses, including changes in protein aggregation, altered HSPA1A function, and modulation of downstream signaling through MAP kinases. This system is particularly relevant for exploring the interplay between chaperone-mediated protein folding and immune signaling cascades, shedding light on pathologies where T cell proteostasis is compromised, such as lymphomas, autoimmune disorders, and immunodeficiency syndromes.
Researchers can apply the HSPA4L Knockout Jurkat Polyclonal Cells in a variety of experimental paradigms. Heat shock survival assays and protein aggregation assays directly test stress resilience and chaperone capacity. Co-immunoprecipitation with Hsp70 and Western blotting confirm altered interaction networks and expression changes. Flow cytometry using Annexin V staining quantifies apoptosis susceptibility, while RT-qPCR profiles transcriptional responses downstream of heat shock factor activation. This knockout model also supports drug screening for chaperone-targeted therapies, enabling identification of compounds that modulate Hsp70/HSPA4L activity in T cell cancers or inflammatory conditions. Integration with pathway inhibitors can further elucidate crosstalk between MAPK signaling and the heat shock response. For further information, including ordering, validation data, and technical protocols, please contact Ascent Research.
